Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aristolochic acid

This article was originally published in The Tan Sheet

Executive Summary

Pacific BioLogic recalls Orthoflex, six other supplements for containing cancer-causing chemical in herbs Akebia Trifoliata Caulis (Mu Tong) and Asarum Sieboldii Herba cum Radix (Xi Xin), Clayton, Calif. firm says July 31. Company became aware of FDA policy against aristolochic acid-containing supplements in June, began recall, Pacific BioLogic says. Five hundred bottles of product have been sold since Jan. 1, 2000 but no illnesses have been reported, firm stresses. FDA has issued an import alert on such products, as well as letters to industry, health professionals and consumers (1"The Tan Sheet" April 16, p. 9)

You may also be interested in...

Aristolochia Renal Disease Link Reported In Two U.S. Cases

Aristolochic acid-containing botanicals were used by two individuals in the U.S. who developed end-stage renal disease, FDA reports in an April 4 letter urging health professionals to more closely monitor their patients' dietary supplement intake.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts